Selective blockade of tumor angiogenesis
Authors:
- 15 June 2012
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 11 (12) , 2253-2259
Abstract
Blocking tumor angiogenesis is an important goal of cancer therapy, but clinically approved anti-angiogenic agents suffer from limited efficacy and adverse side effects, fueling the need to identif...Keywords
This publication has 58 references indexed in Scilit:
- TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer TypesCancer Cell, 2012
- The dark sides of capillary morphogenesis gene 2The EMBO Journal, 2011
- The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeletonBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Anthrax Toxin Targeting of Myeloid Cells through the CMG2 Receptor Is Essential for Establishment of Bacillus anthracis Infections in MiceCell Host & Microbe, 2010
- Autophagy and the Integrated Stress ResponseMolecular Cell, 2010
- Host-Derived Tumor Endothelial Marker 8 Promotes the Growth of MelanomaCancer Research, 2009
- Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivoProceedings of the National Academy of Sciences, 2009
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- Selection of Anthrax Toxin Protective Antigen Variants That Discriminate between the Cellular Receptors TEM8 and CMG2 and Achieve Targeting of Tumor CellsJournal of Biological Chemistry, 2007